Your browser doesn't support javascript.
loading
Genetic architecture of telomere length in 462,666 UK Biobank whole-genome sequences.
Burren, Oliver S; Dhindsa, Ryan S; Deevi, Sri V V; Wen, Sean; Nag, Abhishek; Mitchell, Jonathan; Hu, Fengyuan; Loesch, Douglas P; Smith, Katherine R; Razdan, Neetu; Olsson, Henric; Platt, Adam; Vitsios, Dimitrios; Wu, Qiang; Codd, Veryan; Nelson, Christopher P; Samani, Nilesh J; March, Ruth E; Wasilewski, Sebastian; Carss, Keren; Fabre, Margarete; Wang, Quanli; Pangalos, Menelas N; Petrovski, Slavé.
Affiliation
  • Burren OS; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Dhindsa RS; Center for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Waltham, MA, USA.
  • Deevi SVV; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Wen S; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Nag A; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Mitchell J; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Hu F; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Loesch DP; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Smith KR; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Razdan N; Biosciences COPD & IPF, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Olsson H; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Platt A; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Vitsios D; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Wu Q; Center for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Waltham, MA, USA.
  • Nelson CP; Department of Cardiovascular Sciences, University of Leicester and Leicester NIHR Biomedical Research Centre, Leicester, UK.
  • Samani NJ; Department of Cardiovascular Sciences, University of Leicester and Leicester NIHR Biomedical Research Centre, Leicester, UK.
  • March RE; Department of Cardiovascular Sciences, University of Leicester and Leicester NIHR Biomedical Research Centre, Leicester, UK.
  • Wasilewski S; Precision Medicine & Biosamples, Oncology R&D, AstraZeneca, Dublin, Ireland.
  • Carss K; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Fabre M; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Wang Q; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Pangalos MN; Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Petrovski S; Department of Haematology, University of Cambridge, Cambridge, UK.
Nat Genet ; 56(9): 1832-1840, 2024 Sep.
Article in En | MEDLINE | ID: mdl-39192095
ABSTRACT
Telomeres protect chromosome ends from damage and their length is linked with human disease and aging. We developed a joint telomere length metric, combining quantitative PCR and whole-genome sequencing measurements from 462,666 UK Biobank participants. This metric increased SNP heritability, suggesting that it better captures genetic regulation of telomere length. Exome-wide rare-variant and gene-level collapsing association studies identified 64 variants and 30 genes significantly associated with telomere length, including allelic series in ACD and RTEL1. Notably, 16% of these genes are known drivers of clonal hematopoiesis-an age-related somatic mosaicism associated with myeloid cancers and several nonmalignant diseases. Somatic variant analyses revealed gene-specific associations with telomere length, including lengthened telomeres in individuals with large SRSF2-mutant clones, compared with shortened telomeres in individuals with clonal expansions driven by other genes. Collectively, our findings demonstrate the impact of rare variants on telomere length, with larger effects observed among genes also associated with clonal hematopoiesis.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Telomere / Biological Specimen Banks / Polymorphism, Single Nucleotide / Whole Genome Sequencing Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Nat Genet Journal subject: GENETICA MEDICA Year: 2024 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Telomere / Biological Specimen Banks / Polymorphism, Single Nucleotide / Whole Genome Sequencing Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Nat Genet Journal subject: GENETICA MEDICA Year: 2024 Document type: Article Country of publication: United States